Abstract

Early-onset colorectal cancer (EOCRC), defined as that diagnosed before the age of 50, accounts for 10–12% of all new colorectal cancer (CRC) diagnoses. Epidemiological data indicate that EOCRC incidence is increasing, despite the observed heterogeneity among countries. Although the cause for such increase remains obscure, ≈13% (range: 9–26%) of EOCRC patients carry pathogenic germline variants in known cancer predisposition genes, including 2.5% of patients with germline pathogenic variants in hereditary cancer genes traditionally not associated with CRC predisposition. Approximately 28% of EOCRC patients have family history of the disease. This article recapitulates current evidence on the inherited syndromes that predispose to EOCRC and its familial component. The evidence gathered support that all patients diagnosed with an EOCRC should be referred to a specialized genetic counseling service and offered somatic and germline pancancer multigene panel testing. The identification of a germline pathogenic variant in a known hereditary cancer gene has relevant implications for the clinical management of the patient and his/her relatives, and it may guide surgical and therapeutic decisions. The relative high prevalence of hereditary cancer syndromes and familial component among EOCRC patients supports further research that helps understand the genetic background, either monogenic or polygenic, behind this increasingly common disease.

Highlights

  • Early-onset colorectal cancer (EOCRC), defined as that diagnosed before the age of 50, accounts for 10–12% of all new colorectal cancer (CRC) diagnoses [1,2]

  • Our results indicated that Polymerase Proofreading-Associated Polyposis (PPAP) constitutes 0.1–0.4% of familial cancer cases, reaching 0.3–0.7% when only familial/early-onset CRC and polyposis patients were considered [49]

  • History of adenomas has been associated with an increased CRC risk, the evidence is scarce and there is no clear consensus: whereas the ESGE guidelines [118] do not recommend screening in individuals with a first degree-relative (FDR) with adenomas, the U.S Multi-Society Task Force of Colorectal Cancer [119], recommend screening for individuals with a FDR affected with an advanced adenoma before age 60

Read more

Summary

Kalyuzhny

Hereditary Cancer Program, Catalan Institute of Oncology, Oncobell Program, Bellvitge Biomedical Research. Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), 28029 Madrid, Spain. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), 28029 Madrid, Spain.

Introduction
Lynch Syndrome
Nonpolyposis Mismatch Repair Proficient EOCRC
APC-Associated Polyposis
NTHL1 Tumor Syndrome
Hamartomatous Polyposis
Juvenile Polyposis
PTEN Hamartoma Tumor Syndrome
RNF43-Associated Serrated Polyposis
GREM1-Associated Mixed Polyposis
2.10. Clinical Consequences of having a Hereditary CRC Syndrome
EOCRC in Non-CRC Cancer Syndromes
Familial Aggregation of CRC in EOCRC
Low Risk Alleles and EOCRC
Genetic Counseling and Genetic Testing Recommendations for EOCRC
Findings
Conclusions
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.